{"@context":{"@vocab":"https://schema.org/","dcterms":"http://purl.org/dc/terms/","prov":"http://www.w3.org/ns/prov#"},"@type":"ItemList","@id":"https://api.morvs.ai/api/v1/entity/SGMT/timeline","_source":{"data_provider":"AI Analytics","brand_name":"MORVS","brand_url":"https://morvs.ai/","data_provider_url":"https://api.morvs.ai","license":"https://api.morvs.ai/license","usage_info":"https://api.morvs.ai/license","rights":"Source-specific terms apply; free or keyless access does not alter them.","generated_at":"2026-10-19T09:01:34.162Z","methodology_url":"https://api.morvs.ai/datasets/","primary_sources":{"sec.*":"https://www.sec.gov/edgar","fda.*":"https://api.fda.gov/","contracts":"https://api.usaspending.gov/","clinical.trials":"https://clinicaltrials.gov/","lobbying.filings":"https://lda.senate.gov/","epa.facilities":"https://echo.epa.gov/","court.dockets":"https://www.courtlistener.com/","cfpb.complaints":"https://www.consumerfinance.gov/data-research/consumer-complaints/","nih.grants":"https://api.reporter.nih.gov/","fed.enforcement":"https://www.federalreserve.gov/supervisionreg/enforcementactions.htm","nhtsa.recalls":"https://api.nhtsa.gov/recalls/"}},"entity":{"entity_id":3552,"canonical_name":"Sagimet Biosciences Inc.","cik":"0001400118","uei":null,"lei":null,"duns":null,"ticker":"SGMT"},"window_days":180,"min_importance":0,"sources_queried":["sec.filings","sec.insider","sec.form144","sec.13dg","fda.recalls","fda.labels","contracts","clinical.trials","lobbying.filings","epa.facilities","uspto.patents","court.dockets","cfpb.complaints","nih.grants","fed.enforcement","nhtsa.recalls","doj.press","dol.form5500"],"importance_reference":{"fda.recall Class I":100,"clinical trial terminated":80,"securities class action":80,"antitrust suit":75,"schedule 13D":75,"patent litigation":70,"form144 large ($50M+)":75,"10-K restatement":75,"phase3 trial completed":70,"EPA significant violator":70,"phase3 trial in progress":60,"insider purchase":50,"phase2 trial":45,"8-K":35,"lobbying filing":30,"fda.label":30,"phase1 trial":30,"fda.recall Class III":25},"vertical_counts":{"clinical":1,"sec":45},"count":46,"timeline":[{"ts":"2026-10-07","kind":"clinical.trial","reporter":"Sagimet Biosciences Inc.","title":"Phase 3 Study of Denifanstat in Participants With Moderate to Severe Acne","security_title":"PHASE3","status":"RECRUITING","accession_number":"NCT07863193","excerpt":"[\"Acne Vulgaris\"]","importance":60},{"ts":"2026-10-07","kind":"sec.filing","form_type":"SCHEDULE 13G","title":"SCHEDULE 13G — Sagimet Biosciences Inc. — 2026-10-07","url_slug":"/sec/cik-0001400118/schedule-13g/0001831942-26-000045","accession_number":"0001831942-26-000045","importance":55},{"ts":"2026-10-01","kind":"sec.filing","form_type":"8-K","title":"8-K — Sagimet Biosciences Inc. — 2026-10-01","url_slug":"/sec/cik-0001400118/8-k/0001193125-26-409335","accession_number":"0001193125-26-409335","importance":35},{"ts":"2026-10-01","kind":"sec.filing","form_type":"424B5","title":"424B5 — Sagimet Biosciences Inc. — 2026-10-01","url_slug":"/sec/cik-0001400118/424b5/0001193125-26-409325","accession_number":"0001193125-26-409325","importance":30},{"ts":"2026-09-30","kind":"sec.filing","form_type":"8-K","title":"8-K — Sagimet Biosciences Inc. — 2026-09-30","url_slug":"/sec/cik-0001400118/8-k/0001193125-26-408224","accession_number":"0001193125-26-408224","importance":35},{"ts":"2026-09-30","kind":"sec.filing","form_type":"424B3","title":"424B3 — Sagimet Biosciences Inc. — 2026-09-30","url_slug":"/sec/cik-0001400118/424b3/0001193125-26-408210","accession_number":"0001193125-26-408210","importance":30},{"ts":"2026-08-17","kind":"sec.filing","form_type":"4","title":"4 — Sagimet Biosciences Inc. — 2026-08-17","url_slug":"/sec/cik-0001400118/4/0001193125-26-354018","accession_number":"0001193125-26-354018","importance":30},{"ts":"2026-08-14","kind":"sec.insider.s","reporter":"Kemble George","title":null,"shares":350987,"price_per_share":10.2328,"usd_value":3591580,"security_title":"Series A Common Stock","importance":38.5915797736},{"ts":"2026-08-14","kind":"sec.filing","form_type":"144","title":"144 — Sagimet Biosciences Inc. — 2026-08-14","url_slug":"/sec/cik-0001400118/144/0001950047-26-008152","accession_number":"0001950047-26-008152","importance":30},{"ts":"2026-08-14","kind":"sec.insider.m","reporter":"Kemble George","title":null,"shares":326618,"price_per_share":6.36,"usd_value":2077290,"security_title":"Series A Common Stock","importance":17.077290480000002},{"ts":"2026-08-14","kind":"sec.insider.m","reporter":"Kemble George","title":null,"shares":24369,"price_per_share":6.36,"usd_value":154987,"security_title":"Series A Common Stock","importance":15.15498684},{"ts":"2026-08-13","kind":"sec.filing","form_type":"8-K","title":"8-K — Sagimet Biosciences Inc. — 2026-08-13","url_slug":"/sec/cik-0001400118/8-k/0001193125-26-347854","accession_number":"0001193125-26-347854","importance":35},{"ts":"2026-08-12","kind":"sec.filing","form_type":"4","title":"4 — Sagimet Biosciences Inc. — 2026-08-12","url_slug":"/sec/cik-0001400118/4/0001193125-26-347407","accession_number":"0001193125-26-347407","importance":30},{"ts":"2026-08-11","kind":"sec.filing","form_type":"10-Q","title":"10-Q — Sagimet Biosciences Inc. — 2026-08-11","url_slug":"/sec/cik-0001400118/10-q/0001193125-26-343441","accession_number":"0001193125-26-343441","importance":45},{"ts":"2026-08-11","kind":"sec.form144","reporter":"GEORGE KEMBLE","title":"Director","shares":20206,"usd_value":193371,"security_title":"Common","approx_sale_date":"2026-08-11","accession_number":"0001950047-26-007964","importance":40.038674284},{"ts":"2026-08-11","kind":"sec.insider.s","reporter":"Kemble George","title":null,"shares":20206,"price_per_share":9.9548,"usd_value":201147,"security_title":"Series A Common Stock","importance":35.2011466888},{"ts":"2026-08-11","kind":"sec.filing","form_type":"8-K","title":"8-K — Sagimet Biosciences Inc. — 2026-08-11","url_slug":"/sec/cik-0001400118/8-k/0001193125-26-343446","accession_number":"0001193125-26-343446","importance":35},{"ts":"2026-08-11","kind":"sec.filing","form_type":"144","title":"144 — Sagimet Biosciences Inc. — 2026-08-11","url_slug":"/sec/cik-0001400118/144/0001950047-26-007964","accession_number":"0001950047-26-007964","importance":30},{"ts":"2026-08-11","kind":"sec.insider.m","reporter":"Kemble George","title":null,"shares":10455,"price_per_share":6.36,"usd_value":66494,"security_title":"Series A Common Stock","importance":15.0664938},{"ts":"2026-08-11","kind":"sec.insider.m","reporter":"Kemble George","title":null,"shares":9751,"price_per_share":6.36,"usd_value":62016,"security_title":"Series A Common Stock","importance":15.06201636},{"ts":"2026-07-30","kind":"sec.filing","form_type":"SCHEDULE 13G","title":"SCHEDULE 13G — Sagimet Biosciences Inc. — 2026-07-30","url_slug":"/sec/cik-0001400118/schedule-13g/0002012383-26-003143","accession_number":"0002012383-26-003143","importance":55},{"ts":"2026-07-22","kind":"sec.filing","form_type":"4","title":"4 — Sagimet Biosciences Inc. — 2026-07-22","url_slug":"/sec/cik-0001400118/4/0001193125-26-312397","accession_number":"0001193125-26-312397","importance":30},{"ts":"2026-07-22","kind":"sec.filing","form_type":"4","title":"4 — Sagimet Biosciences Inc. — 2026-07-22","url_slug":"/sec/cik-0001400118/4/0001193125-26-312386","accession_number":"0001193125-26-312386","importance":30},{"ts":"2026-07-22","kind":"sec.filing","form_type":"4","title":"4 — Sagimet Biosciences Inc. — 2026-07-22","url_slug":"/sec/cik-0001400118/4/0001193125-26-312394","accession_number":"0001193125-26-312394","importance":30},{"ts":"2026-07-21","kind":"sec.filing","form_type":"8-K","title":"8-K — Sagimet Biosciences Inc. — 2026-07-21","url_slug":"/sec/cik-0001400118/8-k/0001193125-26-309334","accession_number":"0001193125-26-309334","importance":35},{"ts":"2026-07-20","kind":"sec.form144","reporter":"GEORGE KEMBLE","title":"Director, Officer","shares":18844,"usd_value":147360,"security_title":"Common","approx_sale_date":"2026-07-20","accession_number":"0001950047-26-007226","importance":40.029472016},{"ts":"2026-07-20","kind":"sec.insider.s","reporter":"Happel David","title":"President & CEO","shares":64051,"price_per_share":7.7605,"usd_value":497068,"security_title":"Series A Common Stock","importance":35.4970677855},{"ts":"2026-07-20","kind":"sec.insider.s","reporter":"Kemble George","title":null,"shares":18844,"price_per_share":7.4575,"usd_value":140529,"security_title":"Series A Common Stock","importance":35.14052913},{"ts":"2026-07-20","kind":"sec.insider.s","reporter":"Rozek Elizabeth","title":"Chief Legal & Admin. Officer","shares":10545,"price_per_share":7.7603,"usd_value":81832,"security_title":"Series A Common Stock","importance":35.0818323635},{"ts":"2026-07-20","kind":"sec.filing","form_type":"144","title":"144 — Sagimet Biosciences Inc. — 2026-07-20","url_slug":"/sec/cik-0001400118/144/0001950047-26-007226","accession_number":"0001950047-26-007226","importance":30},{"ts":"2026-06-15","kind":"sec.filing","form_type":"4","title":"4 — Sagimet Biosciences Inc. — 2026-06-15","url_slug":"/sec/cik-0001400118/4/0001104659-26-074050","accession_number":"0001104659-26-074050","importance":30},{"ts":"2026-06-15","kind":"sec.filing","form_type":"4","title":"4 — Sagimet Biosciences Inc. — 2026-06-15","url_slug":"/sec/cik-0001400118/4/0001104659-26-074052","accession_number":"0001104659-26-074052","importance":30},{"ts":"2026-06-15","kind":"sec.filing","form_type":"4","title":"4 — Sagimet Biosciences Inc. — 2026-06-15","url_slug":"/sec/cik-0001400118/4/0001104659-26-074044","accession_number":"0001104659-26-074044","importance":30},{"ts":"2026-06-15","kind":"sec.filing","form_type":"4","title":"4 — Sagimet Biosciences Inc. — 2026-06-15","url_slug":"/sec/cik-0001400118/4/0001104659-26-074045","accession_number":"0001104659-26-074045","importance":30},{"ts":"2026-06-12","kind":"sec.filing","form_type":"8-K","title":"8-K — Sagimet Biosciences Inc. — 2026-06-12","url_slug":"/sec/cik-0001400118/8-k/0001104659-26-073431","accession_number":"0001104659-26-073431","importance":35},{"ts":"2026-06-03","kind":"sec.filing","form_type":"8-K","title":"8-K — Sagimet Biosciences Inc. — 2026-06-03","url_slug":"/sec/cik-0001400118/8-k/0001104659-26-070126","accession_number":"0001104659-26-070126","importance":35},{"ts":"2026-06-01","kind":"sec.filing","form_type":"4","title":"4 — Sagimet Biosciences Inc. — 2026-06-01","url_slug":"/sec/cik-0001400118/4/0001104659-26-069121","accession_number":"0001104659-26-069121","importance":30},{"ts":"2026-06-01","kind":"sec.filing","form_type":"4","title":"4 — Sagimet Biosciences Inc. — 2026-06-01","url_slug":"/sec/cik-0001400118/4/0001104659-26-069122","accession_number":"0001104659-26-069122","importance":30},{"ts":"2026-06-01","kind":"sec.filing","form_type":"4","title":"4 — Sagimet Biosciences Inc. — 2026-06-01","url_slug":"/sec/cik-0001400118/4/0001104659-26-069123","accession_number":"0001104659-26-069123","importance":30},{"ts":"2026-06-01","kind":"sec.filing","form_type":"4","title":"4 — Sagimet Biosciences Inc. — 2026-06-01","url_slug":"/sec/cik-0001400118/4/0001104659-26-069124","accession_number":"0001104659-26-069124","importance":30},{"ts":"2026-05-14","kind":"sec.filing","form_type":"3","title":"3 — Sagimet Biosciences Inc. — 2026-05-14","url_slug":"/sec/cik-0001400118/3/0001104659-26-061323","accession_number":"0001104659-26-061323","importance":30},{"ts":"2026-05-14","kind":"sec.filing","form_type":"4","title":"4 — Sagimet Biosciences Inc. — 2026-05-14","url_slug":"/sec/cik-0001400118/4/0001104659-26-061327","accession_number":"0001104659-26-061327","importance":30},{"ts":"2026-05-12","kind":"sec.filing","form_type":"10-Q","title":"10-Q — Sagimet Biosciences Inc. — 2026-05-12","url_slug":"/sec/cik-0001400118/10-q/0001104659-26-059006","accession_number":"0001104659-26-059006","importance":45},{"ts":"2026-05-12","kind":"sec.filing","form_type":"8-K","title":"8-K — Sagimet Biosciences Inc. — 2026-05-12","url_slug":"/sec/cik-0001400118/8-k/0001104659-26-059009","accession_number":"0001104659-26-059009","importance":35},{"ts":"2026-04-27","kind":"sec.filing","form_type":"8-K","title":"8-K — Sagimet Biosciences Inc. — 2026-04-27","url_slug":"/sec/cik-0001400118/8-k/0001104659-26-048971","accession_number":"0001104659-26-048971","importance":35},{"ts":"2026-04-27","kind":"sec.filing","form_type":"8-K","title":"8-K — Sagimet Biosciences Inc. — 2026-04-27","url_slug":"/sec/cik-0001400118/8-k/0001104659-26-049015","accession_number":"0001104659-26-049015","importance":35}]}